|
|
Effect of the expression level of Th1/Th2 cell line in asthma BALB/c mice immunized with Dust Mite Nano Vaccine |
ZHAO-Miao1 CHEN Xiao-Hong2 |
1.Department of Laboratory,the ENT Hospital in Longgang District of Shenzhen City,Guangdong Province,Shenzhen 518100,China;2.Department of Otolaryngology,the Eighth Affiliated Hospital of Sun Yat-sen University in Shenzhen City,Guangdong Province,Shenzhen 518100,China |
|
|
Abstract Objective To investigate the effect of the expression level of Th1/Th2 cell line in asthma BALB/c mice immunized with Dust Mite Nano Vaccine.Methods A total of 60 female mice were randomly divided into the asthma model group,the vaccine treatment group and the negative control group,with 20 mice in each group.After the models were established,the vaccine treatment group was treated with the Dust Mite Nano Vaccine,while the asthma model group and the negative control group were given normal saline.Peripheral blood was taken to measure the expression of Th1/Th2 cytokines IFN-γ,IL-4 and IL-5 in peripheral blood after the completion of the model and the end of the treatment course.Results After successful modeling,the levels of Th1 cytokine IFN-γ in the asthma model group and the vaccine treatment group were significantly lower than those in the negative control group,Th2 cytokines IL-4 and IL-5 were significantly higher than those in the negative control group,and the differences were statistically significant(P<0.05).After the treatment,the IFN-γ in the vaccine treatment group was higher than that after modeling,IL-4 and IL-5 were significantly lower than those after modeling,and the differences were statistically significant(P<0.05).After treatment,the level of IFN-γ in the asthma model group([82.74±13.27]ng/L)and the vaccine treatment group([101.47±15.44]ng/L)were significantly lower than that in the negative control group ([112.37±16.47]ng/L),IL-4 in the asthma model group([30.16±2.62]ng/L)and the vaccine treatment group([22.36±2.23]ng/L)were higher than that in the negative control group([18.32±1.41]ng/L),IL-5 in the asthma model group([30.74±4.53]ng/L)and the vaccine treatment group([16.36±2.97]ng/L)were higher than that in the negative control group ([12.46±2.68]ng/L),and the differences were statistically significant(P<0.05).After treatment,there was no statistically significant difference in Th1/Th2 cell line expression between the asthma model group and the vaccine treatment group (P>0.05).Conclusion Dust Mite Nano Vaccine can significantly correct the imbalance of Th1/Th2 cell line cytokine expression function in asthma BALB/c mice.
|
|
|
|
|
[1] |
刘芳英,黄海茵,姚亮,等.中医外治法在支气管哮喘治疗中的临床研究概述[J].临床肺科杂志,2015,3(7):1315-1318.
|
[2] |
曾山,熊彬.激素抵抗型哮喘与炎性因子相关性的研究进展[J].广东医学,2017,38(3):478-480.
|
[3] |
Ji NF,Xie YC,Zhang MS,et al.Ligustrazine corrects Th1/Th2 and Treg/Th17 imbalance in a mouse asthma model[J].Int Immunopharmacol,2015,21(1):76.
|
[4] |
田祖慧,左凤琼,张魏.哮喘患儿诱导痰中T细胞亚群和细胞因子的变化及意义[J].海南医学院学报,2016,22(1):72-74.
|
[5] |
李燕,谢敏,史小玲,等.HSP70/CD80 DNA疫苗通过调节Th1/Th2/Treg/Th17细胞对小鼠急性哮喘的抑制作用[J].山东大学学报(医学版),2014,52(10):20.
|
[6] |
刘欣欣,陈立新,王莹,等.特异性免疫治疗对BALB/c小鼠特应性皮炎模型的疗效观察[J].中国皮肤性病学杂志,2016(11):1112-1115.
|
[7] |
Pelaia G,Vatrella A,Maselli R.The potential of biologics for the treatment of asthma[J].Nat Rev Drug Discov,2012,11(12):958.
|
[8] |
卞勇华,俞黎黎,黄思怡,等.粉尘螨变应原第2组分真核表达载体的构建及其在小鼠骨髓间充质干细胞中的表达[J].广西医学,2017,39(3):372-375.
|
[9] |
赵晓菲,安高,封桂英,等.Th2型细胞因子在胶原诱导性关节炎小鼠血清中的动态变化[J].职业与健康,2016,32(4):471-474.
|
[10] |
马祥,刘洪,梁宗安,等.哮喘小鼠CD4+CD25+调节性T细胞及相关细胞因子的变化研究[J].西部医学,2016,28(1):15-18.
|
[11] |
李建生,王至婉.支气管哮喘中医证候诊断标准(2016版)[J].中医杂志,2016,57(22):1978-1980.
|
[12] |
赵春兰,于华凤,吕欣.T淋巴细胞在哮喘发病机制中的作用[J].生命的化学,2016,7(6):868-873.
|
[13] |
史兆雯,蔡朱莺.细胞因子与支气管哮喘相关性研究[J].中国医师进修杂志,2017,40(11):1053-1056.
|
[14] |
赵燕,程晓明,王长征,等.Th17应答在哮喘发病机制中作用的研究进展[J].重庆医学,2015,42(2):216.
|
[15] |
朱康,侯晓玲,皇惠杰,等.吸入变应原sIgE在不同气道过敏性疾病儿童中的分布特征[J].中国当代儿科杂志,2017,19(11):1185-1190.
|
[16] |
滕飞翔,孙金霞,王楠,等.应用短肽阵列筛选哮喘患儿血清粉尘螨变应原特异性IgE抗体的结合表位[J].细胞与分子免疫学杂志,2017,33(8):1128-1132.
|
[17] |
Smith DE.IL-33:a tissue derived cytokine pathway involved in allergic inflammation and asthma[J].Clin Experiment All,2016,40(2):200.
|
[18] |
Borish L,Steinke JW.Interleukin-33 in asthma:how big of a role does it play[J].Curr All Asthma Rep,2015,11(1):7.
|
[19] |
龚臣,邓静敏.Th17/Treg在支气管哮喘发病机制中的作用及研究进展[J].中华哮喘杂志(电子版),2015,7(3):201.
|
|
|
|